Tech Company Financing Transactions
Quiver Bioscience Funding Round
On 4/13/2026, Quiver Bioscience raised financing from Porta Hnos..
Transaction Overview
Company Name
Announced On
4/13/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The investment will fund preclinical activities essential to the program, including safety studies for development candidate selection on the path toward clinical development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
150 Cambridge Park Drive
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
Mission: To accelerate discovery of empirically grounded, AI-driven therapeutics that deliver transformative value to patients with neurological disease - all powered through Quiver's innovation engine and strategic partnerships.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Graham Dempsey
Founder
David Margulies
Founder
Paul Roma
President
Dave Liederbach
Vice President
James Fink
Vice President
Luis Williams
VP - Administration
Noélle Germain
VP - Administration
Denise Johnson
VP - Engineering
Yang Lu
VP - Finance
Doug Waage
VP - Regulatory Affairs
David Gerber
Browse more venture capital transactions:
Prev: 4/13/2026: Critical Loop venture capital transaction
Next: 4/13/2026: Surf Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs